top of page

About Us

Our Story

EnLiSense pioneers advanced biosensor technology that transforms how we monitor health. By unlocking the diagnostic potential of sweat, saliva, urine, and blood, we're making real-time biomarker monitoring accessible for both everyday wellness and clinical applications.

 

Our expanding platform tracks critical biomarkers—from stress and inflammation to metabolic health—enabling continuous insights that were previously confined to laboratory settings. Through strategic partnerships with healthcare providers, wellness brands, and research institutions, we're building a future where personalized health monitoring is proactive, precise, and accessible to all.

Founded on principles of scientific rigor, regulatory excellence, and customer focus, EnLiSense is committed to delivering safe, reliable solutions that meet the highest quality standards. Every innovation brings us closer to our vision: transforming healthcare through technology that empowers individuals and supports clinicians in delivering better care.

Biosensing Innovation for Wellness and Healthcare

Meet The Team

Our Clinical Partners

Our Funding Partners

ccf_logo.png

Important Disclaimer

Guidance for Use and Regulatory Status

EnLiSense devices (IBD AWARE, SWEAT AWARE, and CORTI) are for general wellness in healthy individuals, supporting health awareness, fitness, and lifestyle insights. These products are positioned as low-risk general wellness devices under the FDA's "General Wellness: Policy for Low-Risk Devices" guidance issued January 6, 2026. They provide comprehensive wellness monitoring that continuously and non-invasively tracks chemical biomarkers present in sweat. Please note that our devices are not FDA-cleared and cannot be used for medical diagnostic purposes. We do provide our wearable products for clinical studies and research conducted under Institutional Review Board (IRB) oversight. The EnLiSense Wellness Platform holds commercial certifications for the general wellness category, including the CE Mark (EU), UK CA Mark (UK), and certified to FCC (USA).
 

Non General Wellness Use Requires Clinical Oversight
Medical applications, including monitoring or managing diseases are still under investigation. Investigational use require supervision by qualified healthcare professionals in clinical or research settings.
 

No Medical Claims
Mentions of biomarkers or health conditions reflect research goals and are not evaluated by the FDA. All information is for education and wellness only, not as medical advice.
 

Consult Healthcare Professionals
Consult healthcare providers regarding medical concerns or symptoms. Device data does not replace professional medical advice, diagnosis, or treatment. Seek immediate care for urgent symptoms.
 

Limitations
Users accept all risks with device use. EnLiSense is not responsible for health outcomes from device use or data interpretation. Product features and capabilities may change as development continues.

© 2023 - 2026 by EnLiSense | Terms of Service & Privacy Policy

  • LinkedIn
bottom of page